#United States #Lexington #Infertility #Rosalind Franklin University #Reproductive Immunology

Addressing Infertility: Insights from the ASRI Annual Meeting

At the recent American Society of Reproductive Immunology (ASRI) Annual Meeting held in Lexington, Kentucky, groundbreaking research from Rosalind Franklin University (RFU) was presented, underscoring the critical role of reproductive immunology in the fight against infertility. RFU's Reproductive Immunology program has earned the top ranking globally, as recognized by ScholarGPS. This meeting, held from May 24-28, brought together leading experts to share innovative findings that could transform women's health.

One of the highlights was a session led by Dr. Joanne Kwak-Kim, RFU's Director of Reproductive Medicine and Immunology and ranked the seventh-best clinician-scientist in the field. Her session, titled "Breaking Barriers: Innovative Immunotherapies in Human Reproduction," highlighted the integral part of reproductive immunology in diagnosing and addressing immune-mediated infertility issues. With the rise in infertility rates in the U.S., understanding and treating these underlying causes is more critical than ever. In fact, the total fertility rate in the country has plummeted from about 3.6 in 1960 to just 1.6 recently, marking a significant deviation from the replacement level of 2.1 necessary to sustain a stable population without immigration.

Declining birth rates, currently projected at around 3.6 million annually compared to a peak of over 4.3 million in 2007, reflect a broader trend that is certainly concerning. As Dr. Janice Urban, interim executive vice president of research at RFU, noted, "Identifying the factors and mechanisms associated with infertility is a crucial step towards devising effective interventions to enhance successful pregnancy outcomes. The pioneering work of our researchers reflects RFU's commitment as a global leader in reproductive immunology."

Among the presenters were Dr. Thanh Luu, who discussed the role of the endometrial environment in reproductive failure, and Dr. Riyas Ali, whose talk focused on the dose-dependent effects of sex steroid hormones on immune cell behavior in reproductive contexts. Another noteworthy presentation was delivered by Dr. Khaliun Dashdeleg, emphasizing the impact of immunotherapy outcomes in patients with differing ovarian reserves.

Posters showcasing RFU's research further contributed to the dialogue, with significant topics such as:

• - Beyond Ovarian Reserve: Anti-Müllerian Hormone as a direct immune signaling regulator in reproductive failure. This research led by Dr. Umida Ganieva and colleagues sheds light on the interplay between hormone signaling and immune response in fertility.
• - Impaired Immune Plasticity: The differential roles of BMP-7 and SOD3 on specific immune receptors were explored, revealing insights into how immune mechanisms can impact reproductive success.
• - Relationship Between IGF/IGFBP System and Killer Cell Activity: The research conducted by Dr. Ali and others highlighted critical interactions that can influence implantation success and pregnancy maintenance.
• - Autoimmune Modulation: A comprehensive study involving 803 women provided actionable data on the immune-endocrine interactions that regulate ovarian reserve, enhancing the understanding of autoimmune implications on fertility.

Rosalind Franklin University, established in 1912, remains dedicated to advancing health and biomedical education while tackling pressing global health challenges. Their commitment to excellence resonates throughout the research presented at ASRI, solidifying RFU's role at the forefront of reproductive health innovation.

For more information about RFU and its pioneering research, visit rosalindfranklin.edu.